Cargando…
A Chemical Analog of Curcumin as an Improved Inhibitor of Amyloid Abeta Oligomerization
Amyloid-like plaques are characteristic lesions defining the neuropathology of Alzheimer's disease (AD). The size and density of these plaques are closely associated with cognitive decline. To combat this disease, the few therapies that are available rely on drugs that increase neurotransmissio...
Autores principales: | Orlando, Robert A., Gonzales, Amanda M., Royer, Robert E., Deck, Lorraine M., Vander Jagt, David L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3307704/ https://www.ncbi.nlm.nih.gov/pubmed/22442659 http://dx.doi.org/10.1371/journal.pone.0031869 |
Ejemplares similares
-
Substituted trans-stilbenes can inhibit or enhance the TPA-induced up-regulation of activator protein-1
por: Deck, Lorraine M, et al.
Publicado: (2008) -
Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator
por: Heynekamp, Justin J, et al.
Publicado: (2006) -
Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota
por: Harach, T., et al.
Publicado: (2017) -
Is abeta a sufficient biomarker for monitoring anti-abeta clinical studies? A critical review
por: Moreth, Jens, et al.
Publicado: (2013) -
Site specific NMR characterization of abeta-40 oligomers cross seeded by abeta-42 oligomers
por: Chang, Han-Wen, et al.
Publicado: (2022)